Motion text
That this House notes that an estimated 1.6 million people are living with atrial fibrillation in the UK; acknowledges that atrial fibrillation is a contributing factor in one in five strokes; welcomes the NHS’s commitment to improve the early detection and treatment of atrial fibrillation; further notes NHS England’s commitment to expand access to direct oral anticoagulants to help prevent 21,700 strokes and save 5,400 lives over a three-year period; further acknowledges that anticoagulants carry an increased risk of life-threatening bleeding, particularly within the gastrointestinal tract; recognises that the increase in anticoagulation medication will likely lead to an increased number of associated bleeds; further acknowledges the variation within the management of anticoagulation-associated bleeds; urges the National Institute for Health and Care Excellence to review and update clinical guidelines to improve outcomes within the management of anticoagulation-associated bleeds; and calls on NHS England to establish policies to reduce the variation within the management of anticoagulation-associated bleeds and improve patient outcomes.
Signatures (5)
The first 6 Members who have signed to support the motion are the sponsors. The primary sponsor is generally the person who tabled the motion and has responsibility for it. The date shown is when the Member signed the motion.
There are no withdrawn signatures for this motion.